- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05674643
Gastric Assessment of Pediatric Patients Undergoing Surgery
The goal of this pilot prospective cohort study is to examine the reproducibility of gastric volume and emptying as measured by gastric ultrasound and its correlation to a gold-standard test for gastric emptying in the perioperative period in pediatric patients. The main questions it aims to answer are:
- What is the reliability (inter-rater variability between expert and novice assessors, and intra-rater variability) of a) the gastric antral cross-sectional area (CSA) and b) gastric volume using the Perlas US qualitative grading assessment, measured by using an ultrasound device in pediatric patients undergoing general anesthesia for elective surgery?
- What is the correlation between ultrasound assessment of gastric emptying by the antral-CSA and gastric emptying determined by the acetaminophen absorption test (AAT), the gold standard?
The study will include two cohorts. Cohort assignment will be based on age and anesthesia induction plan. Subjects >7yrs of age and expected to get an IV induction will be assigned to Cohort #1. Subjects <7yrs of age and not expected to get an IV induction will be assigned to Cohort #2.
- Cohort 1 will include abdominal ultrasound for gastric assessment AND the acetaminophen absorption test which includes administering enteral acetaminophen (tylenol) with 6 oz of water and drawing of blood samples through a peripheral intravenous line.
- Cohort 2 will include subjects for whom a peripheral intravenous line placement is not part of routine pre-operative care. Procedures for Cohort 2 will include abdominal ultrasound only in the pre-op area (no tylenol). This cohort is included to examine the reliability of measurements across age groups.
Study Overview
Status
Conditions
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Rachel Bernier, MPH
- Phone Number: 857-218-5348
- Email: rachel.bernier@childrens.harvard.edu
Study Contact Backup
- Name: Jocelyn Booth, BSN
- Phone Number: 857-218-4585
- Email: jocelyn.booth@childrens.harvard.edu
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02115
- Recruiting
- Boston Children's Hospital
-
Contact:
- Rachel Bernier, MPH
- Phone Number: 18572185348
- Email: rachel.bernier@childrens.harvard.edu
-
Principal Investigator:
- Walid Alrayashi, MD
-
Sub-Investigator:
- Enid Martinez, MD
-
Contact:
- Jocelyn Booth, BSN
- Phone Number: 857-218-4585
- Email: jocelyn.booth@childrens.harvard.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Perioperative patients with ASA classification 1-2
- Ages: 2 years- less than 18 years
- Locations: Longwood and Waltham campuses of Boston Childrens Hospital
Exclusion Criteria:
- History of gastrointestinal surgery
- Gastrostomy
- Known GI dysmotility (cohort 1 only)
- Acetaminophen allergy (cohort 1 only)
- Liver or renal dysfunction- pre-diagnosed or, if available, when serum biomarkers are 2 standard deviations above the highest value considered normal for age. (cohort 1 only)
- Consumption of acetaminophen in the 4 hours prior (cohort 1 only)
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Cohort 1 - ultrasound and acetaminophen
Cohort 1 will include subjects who have a peripheral intravenous line placed in the pre-op area per routine care.
This cohort is on average age 7 years and older.
Procedures for cohort 1 will include: (a) gastric US measurement of the antral CSA and gastric volume using the Perlas US qualitative grading assessment by an expert and a novice operator to determine the inter-rater class reliability and repeat measurements by each operator to assess the intra-rater reliability (Aim 1), and (b) serial abdominal ultrasounds for gastric assessment and the acetaminophen absorption test to determine the correlation between gastric US and a gold-standard for gastric emptying (Aim 2).
The acetaminophen absorption test requires administering a single weight-based enteral dose of acetaminophen with 6 oz of water and drawing of blood samples through a peripheral intravenous line.
|
The patient's abdomen will be scanned using the ultrasound device by an expert scanner and novice scanner for baseline assessment of the antral CSA and gastric volume using Perlas US qualitative grading assessment.
Prior to starting the AAT, a baseline plasma acetaminophen level (250 microliters) will be obtained from the intravenous catheter. The subject will then be given 12.5 mg/kg or max 650mg of single batch 32mg/mL acetaminophen followed by 6oz of water PO. Up to 3 additional small volume blood samples will be drawn for acetaminophen levels. These additional blood samples (250 microliters each) will be obtained to measure acetaminophen plasma levels at the following goal intervals after acetaminophen administration.T1:10-20 mins, T2:35-45 mins, T3: 60mins. At the time of each lab draw gastric ultrasound will be assessed by the expert scanner to correlate gastric ultrasound with the acetaminophen absorption test as a gold-standard of gastric emptying.
Cohort 1 will have multiple scans as part of assessing gastric emptying.
These sequential scans after the baseline assessment will be done in line with the Acetaminophen Absorption Test timeline (T1:10-20 mins, T2:35-45 mins, T3: 60mins) and will be performed by an expert scanner only.
|
Cohort 2 - ultrasound only
Cohort 2 will include subjects for whom a peripheral intravenous line placement is not part of routine pre-operative care.
Average age for cohort 2 is age less than 7 years old.
Procedures for Cohort 2 will include a gastric US measurement of the antral CSA and gastric volume using Perlas US qualitative grading assessment by an expert and a novice operator to determine the inter-rater class reliability and repeat measurements by each operator for the intra-rater reliability (Aim 1).
This cohort is included to examine the reliability of measurements across age groups.
|
The patient's abdomen will be scanned using the ultrasound device by an expert scanner and novice scanner for baseline assessment of the antral CSA and gastric volume using Perlas US qualitative grading assessment.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Inter-rater reliability
Time Frame: 1 year
|
Measured using the following quantitative and qualitative ultrasound assessments between a novice and an expert gastric ultrasound operator:
|
1 year
|
Intra-rater reliability
Time Frame: 1 year
|
Measured using the following quantitative and qualitative ultrasound assessments between a novice and an expert gastric ultrasound operator:
|
1 year
|
Gastric Emptying
Time Frame: 1 year
|
Outcome will be gastric emptying assessed by the change in antral CSA (measured in cm2) over time after acetaminophen administration, and this will be correlated to gastric emptying over the same period of time by the acetaminophen absorption test PK parameter, AUC60 mcg*min/mL.
As such, each patient will act as their own control.
Correlation analysis will be applied to examine the performance of CSA measurements overtime using gastric ultrasound to determine gastric emptying compared to the acetaminophen absorption test as the gold standard.
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Post-anesthetic outcomes
Time Frame: 1 year
|
Fasting times have been correlated to post-anesthetic outcomes such as post-operative nausea/ vomiting, and discomfort, and it is known that some patients fast longer than required by their clinical team, which can result in adverse effects.
Reported fasting times for all patients and confirmatory assessment by gastric US will be examined along with data pulled from the medical record about post-operative nausea/ vomiting, post-operative discomfort, satisfaction, and whether the patient met their expected post-operative trajectory or not (e.g.
unplanned admission).
|
1 year
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Digestive System Diseases
- Pathologic Processes
- Infections
- Respiratory Tract Infections
- Respiratory Tract Diseases
- Respiration Disorders
- Pneumonia
- Lung Diseases
- Neurologic Manifestations
- Gastrointestinal Diseases
- Stomach Diseases
- Esophageal Motility Disorders
- Deglutition Disorders
- Esophageal Diseases
- Paralysis
- Gastroesophageal Reflux
- Laryngopharyngeal Reflux
- Respiratory Aspiration
- Pneumonia, Aspiration
- Gastroparesis
- Respiratory Aspiration of Gastric Contents
- Physiological Effects of Drugs
- Peripheral Nervous System Agents
- Analgesics
- Sensory System Agents
- Analgesics, Non-Narcotic
- Antipyretics
- Acetaminophen
Other Study ID Numbers
- IRB-P00040829
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Aspiration Pneumonia
-
UConn HealthRecruiting
-
Fundación Cardiovascular de ColombiaCompletedAspiration PneumoniasColombia
-
Assistance Publique - Hôpitaux de ParisCompletedAspiration Pneumonia | Rapid Sequence Induction of General Anesthesia | Sellick Maneuver | Acid Aspiration Syndrome | Lung AspirationFrance
-
Assistance Publique Hopitaux De MarseilleUnknownEarly Aspiration PneumoniaFrance
-
University Hospital, LilleRecruitingAspiration PneumoniaFrance
-
University of Wisconsin, MadisonGordon and Betty Moore FoundationCompleted
-
University Hospitals Cleveland Medical CenterWithdrawn
-
National Taipei University of Nursing and Health...Taipei Veterans General Hospital, TaiwanRecruitingAspiration PneumoniaTaiwan
-
ART Medical Ltd.TerminatedAspiration PneumoniaUnited States
-
ART Medical Ltd.CompletedAspiration PneumoniaIsrael
Clinical Trials on Gastric Ultrasound Baseline Scans
-
Smart Alfa Teknoloji San. ve Tic. A.S.Ankara UniversityCompletedUltrasound Imaging of Anatomical Structures | Nerve BlockTurkey
-
IntelligentUltrasound LimitedCompletedUltrasound Imaging of Anatomical StructuresUnited States
-
Samuel Lunenfeld Research Institute, Mount Sinai...CompletedPregnancy | Respiratory Aspiration of Gastric ContentCanada
-
Hospices Civils de LyonCompleted
-
Columbia UniversityRecruiting
-
Prince of Wales Hospital, Shatin, Hong KongCompleted
-
Centre Hospitalier Universitaire DijonCompletedIntensive Care | ExtubationFrance
-
Hospices Civils de LyonRecruitingPediatric ALL | Fasting | AspirationFrance
-
Mahidol UniversityRecruitingLearning Curve | Gastric Ultrasound | Novel in Gastric UltrasoundThailand